Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Butterfly Network, Inc.BFLY · Entity 4467 | Director | June 17, 2022 | June 22, 2022 |
| Change Healthcare Inc.CHNG · Entity 15437 | Director | June 27, 2019 | June 27, 2019 |
| MCKESSON CORPMCK · Entity 2904 | Director · Chairman, President & CEO | May 30, 2018 | May 31, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Butterfly Network, Inc.
Report date June 17, 2022 · Filed June 22, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 61,388 |
Reported balance
After 2022-06-17 transaction · row 1
1 source rowRow 1 · 2022-06-17 · Grant · Acquired 48,231 · Balance 61,388 F1: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs were issued to the Reporting Person as the annual grant to nonemployee directors pursuant to the Issuer's Amended and Restated Nonemployee Director Compensation Policy for services to be rendered to the Issuer as a member of its Board of Directors. The RSUs vest in full on the date of the Issuer's 2023 Annual Stockholders Meeting, subject to the Reporting Person's continued service on the Board of Directors on such date. |
| Class A Common StockSEC Table I · non-derivative | IndirectHeld by Triumph Ventures LP | 120,099 |
Reported balance
Holding disclosure · report date 2022-06-17 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 120,099 F2: Mr. Hammergren is the President of The Stoneyfield Group LLC, the General Partner of Triumph Ventures LP. Mr. Hammergren disclaims beneficial ownership of the securities held by Triumph Ventures LP except to the extent of his pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs were issued to the Reporting Person as the annual grant to nonemployee directors pursuant to the Issuer's Amended and Restated Nonemployee Director Compensation Policy for services to be rendered to the Issuer as a member of its Board of Directors. The RSUs vest in full on the date of the Issuer's 2023 Annual Stockholders Meeting, subject to the Reporting Person's continued service on the Board of Directors on such date.
F2: Mr. Hammergren is the President of The Stoneyfield Group LLC, the General Partner of Triumph Ventures LP. Mr. Hammergren disclaims beneficial ownership of the securities held by Triumph Ventures LP except to the extent of his pecuniary interest therein.
Change Healthcare Inc.
Report date June 27, 2019 · Filed June 27, 2019
This filing explicitly reported no securities owned.
MCKESSON CORP
Report date May 30, 2018 · Filed May 31, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock Option (Right-to-buy)SEC Table II · derivative / convertible security · Conversion / exercise price $144.43 · Expires 2025-05-30 | Direct | 84,318 |
Reported balance
After 2018-05-30 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2018-05-30 · Grant · Acquired 84,318 · Balance 84,318 F1: This option granted 5/30/2018 vests 25% annually commencing on the first anniversary of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: This option granted 5/30/2018 vests 25% annually commencing on the first anniversary of the grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 06, 2016 Filed Sep 8, 2016 00:21 UTC | MCKESSON CORP MCK · Entity 2904 | Exercise / conversionEmployee Stock Option (Right-to-buy) · Derivative | 100,500 | $0.00 Strike: $67.81 | $0.00 |
DisclosureSEC source: 0001443873-16-000049 · edgar.xml · derivative · entry 5 HAMMERGREN JOHN H · CIK 0001197887 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 301,500 Underlying: Common Stock · 100,500 shares Expires 2017-05-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Option exercise and sale pursuant to a previously adopted plan, intended to comply with Rule 10b5-1(c). F3 · derivative.exercise_date: This option granted 05/25/2010 vested 25% per year, commencing on the 1st anniversary of the grant date. Read SEC document |
| September 06, 2016 Filed Sep 8, 2016 00:21 UTC | MCKESSON CORP MCK · Entity 2904 | SaleCommon Stock | 100,500 | $184.22 | $18,513,939.15 |
DisclosureSEC source: 0001443873-16-000049 · edgar.xml · nonDerivative · entry 2 HAMMERGREN JOHN H · CIK 0001197887 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: Option exercise and sale pursuant to a previously adopted plan, intended to comply with Rule 10b5-1(c). Read SEC document |
| September 06, 2016 Filed Sep 8, 2016 00:21 UTC | MCKESSON CORP MCK · Entity 2904 | Exercise / conversionCommon Stock | 100,500 | $67.81 | $6,814,905.00 |
DisclosureSEC source: 0001443873-16-000049 · edgar.xml · nonDerivative · entry 1 HAMMERGREN JOHN H · CIK 0001197887 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Option exercise and sale pursuant to a previously adopted plan, intended to comply with Rule 10b5-1(c). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.